<p>(<i>A</i>) The induction of LTP in the hippocampal DG requires activation of NMDARs. A stable basal level of fEPSPs was obtained by electrical stimulation of MPP (0.05 Hz) from the DG of anesthetized rats and LTP was induced by application of sTPS through the same stimulation electrode. Representative traces of fEPSP on the left were averages of all individual recordings before and after the establishment of LTP. Systemic application of the competitive NMDAR antagonist CPP (10 mg/kg) prevented the induction of LTP (CPP+sTPS), without affecting basal level of fEPSP (0.05 Hz+CPP). (<i>B</i>) LTP increases the total numbers of PCNA-positive immature neurons in the DG. Representative images from coronal sections from non-LTP (0.05 Hz+ saline...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
The effects of the novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist, CGP 39551 [the...
<p>(<i>A</i>) Schematic representation of the experimental design. (<i>B</i>) The induction of LTP i...
<p>(<i>A)</i> Schematic representation of the experimental design. (<i>B</i>) NMDAR-dependent LTP in...
<p>(<i>A</i>) Schematic representation of the experimental design. GFP-labeled NSCs were co-cultured...
grantor: University of TorontoLong-term potentiation (LTP) is an activity-dependent streng...
<p><i> Left:</i> Normalized slopes of evoked fEPSPs recorded as those in <a href="http://www.plosone...
<p><b><i>A.</i></b> Evoked fEPSPs normalized slopes from fresh hippocampal slices corresponding to t...
<p><b>A</b>, Schematic representation of the slice preparation showing positions of stimulation (S<s...
The activation of N-methyl-D-aspartate glutamate receptors (NMDARs) is required for the long term po...
The activation of N-methyl-D-aspartate glutamate receptors (NMDARs) is required for the long term po...
NMDA receptor (NMDAR) 2A (NR2A)- and NR2B-type NMDARs coexist in synapses of CA1 pyramidal cells. Re...
NMDA receptor (NMDAR) 2A (NR2A)- and NR2B-type NMDARs coexist in synapses of CA1 pyramidal cells. Re...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
The effects of the novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist, CGP 39551 [the...
<p>(<i>A</i>) Schematic representation of the experimental design. (<i>B</i>) The induction of LTP i...
<p>(<i>A)</i> Schematic representation of the experimental design. (<i>B</i>) NMDAR-dependent LTP in...
<p>(<i>A</i>) Schematic representation of the experimental design. GFP-labeled NSCs were co-cultured...
grantor: University of TorontoLong-term potentiation (LTP) is an activity-dependent streng...
<p><i> Left:</i> Normalized slopes of evoked fEPSPs recorded as those in <a href="http://www.plosone...
<p><b><i>A.</i></b> Evoked fEPSPs normalized slopes from fresh hippocampal slices corresponding to t...
<p><b>A</b>, Schematic representation of the slice preparation showing positions of stimulation (S<s...
The activation of N-methyl-D-aspartate glutamate receptors (NMDARs) is required for the long term po...
The activation of N-methyl-D-aspartate glutamate receptors (NMDARs) is required for the long term po...
NMDA receptor (NMDAR) 2A (NR2A)- and NR2B-type NMDARs coexist in synapses of CA1 pyramidal cells. Re...
NMDA receptor (NMDAR) 2A (NR2A)- and NR2B-type NMDARs coexist in synapses of CA1 pyramidal cells. Re...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
Potentiation at synapses between CA3 and the CA1 pyramidal neurons comprises both transient and sust...
The effects of the novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist, CGP 39551 [the...